Suppr超能文献

相似文献

1
Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk.
Gastroenterology. 2022 Feb;162(2):439-453. doi: 10.1053/j.gastro.2021.10.016. Epub 2021 Oct 21.
2
Real-world efficacy of dupilumab in four cases of paediatric-onset fibrostenotic eosinophilic esophagitis.
Clin Exp Pharmacol Physiol. 2024 Aug;51(8):e13903. doi: 10.1111/1440-1681.13903.
3
A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease.
Gastrointest Endosc. 2014 Apr;79(4):577-85.e4. doi: 10.1016/j.gie.2013.10.027. Epub 2013 Nov 23.
5
Fibrostenotic eosinophilic esophagitis might reflect epithelial lysyl oxidase induction by fibroblast-derived TNF-α.
J Allergy Clin Immunol. 2019 Jul;144(1):171-182. doi: 10.1016/j.jaci.2018.10.067. Epub 2018 Dec 20.
6
Outcomes of Esophageal Dilation in Eosinophilic Esophagitis: Safety, Efficacy, and Persistence of the Fibrostenotic Phenotype.
Am J Gastroenterol. 2016 Feb;111(2):206-13. doi: 10.1038/ajg.2015.399. Epub 2016 Jan 12.
8
Eosinophilic Esophagitis-Associated Chemical and Mechanical Microenvironment Shapes Esophageal Fibroblast Behavior.
J Pediatr Gastroenterol Nutr. 2016 Aug;63(2):200-9. doi: 10.1097/MPG.0000000000001100.
9
Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice.
Am J Physiol Gastrointest Liver Physiol. 2016 Jan 1;310(1):G13-25. doi: 10.1152/ajpgi.00290.2015. Epub 2015 Oct 29.
10

引用本文的文献

1
Systematic Review: Variability in Definitions of Fibrostenosis in Eosinophilic Oesophagitis.
Aliment Pharmacol Ther. 2025 Aug;62(3):277-299. doi: 10.1111/apt.70187. Epub 2025 Jun 19.
2
The oesophagus as an immune organ.
Nat Rev Gastroenterol Hepatol. 2025 Jun 18. doi: 10.1038/s41575-025-01086-4.
3
Advances in omics data for eosinophilic esophagitis: moving towards multi-omics analyses.
J Gastroenterol. 2024 Nov;59(11):963-978. doi: 10.1007/s00535-024-02151-6. Epub 2024 Sep 19.
4
Eosinophilic Esophagitis and Inflammatory Bowel Disease: What Are the Differences?
Int J Mol Sci. 2024 Aug 5;25(15):8534. doi: 10.3390/ijms25158534.
5
Losartan Treatment Reduces Esophageal Eosinophilic Inflammation in a Subset of Eosinophilic Esophagitis.
J Allergy Clin Immunol Pract. 2024 Sep;12(9):2427-2438.e3. doi: 10.1016/j.jaip.2024.07.011. Epub 2024 Jul 25.
7
Development and dysfunction of structural cells in eosinophilic esophagitis.
J Allergy Clin Immunol. 2024 Jun;153(6):1485-1499. doi: 10.1016/j.jaci.2024.04.006.
8
Nonepithelial Gene Expression Correlates With Symptom Severity in Adults With Eosinophilic Esophagitis.
J Allergy Clin Immunol Pract. 2024 Dec;12(12):3346-3355.e1. doi: 10.1016/j.jaip.2024.05.015. Epub 2024 May 18.
9
Eosinophilic esophagitis: Current concepts in diagnosis and management.
Saudi J Gastroenterol. 2024 Jul 1;30(4):210-227. doi: 10.4103/sjg.sjg_50_24. Epub 2024 May 16.
10
Clinical and molecular correlates of the Index of Severity for Eosinophilic Esophagitis.
J Allergy Clin Immunol. 2024 Aug;154(2):375-386.e4. doi: 10.1016/j.jaci.2024.04.025. Epub 2024 May 13.

本文引用的文献

1
Broad transcriptional response of the human esophageal epithelium to proton pump inhibitors.
J Allergy Clin Immunol. 2021 May;147(5):1924-1935. doi: 10.1016/j.jaci.2020.09.039. Epub 2020 Oct 23.
2
Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis.
Gastroenterology. 2020 Nov;159(5):1672-1685.e5. doi: 10.1053/j.gastro.2020.07.039. Epub 2020 Jul 25.
3
4
Robust production of IL-33 and TSLP by lung endothelial cells in response to low-dose dsRNA stimulation.
J Allergy Clin Immunol. 2020 Dec;146(6):1449-1452.e2. doi: 10.1016/j.jaci.2020.03.042. Epub 2020 Apr 28.
5
Diagnosis and treatment of eosinophilic esophagitis.
J Allergy Clin Immunol. 2020 Jan;145(1):1-7. doi: 10.1016/j.jaci.2019.11.011.
6
Identification of anoctamin 1 (ANO1) as a key driver of esophageal epithelial proliferation in eosinophilic esophagitis.
J Allergy Clin Immunol. 2020 Jan;145(1):239-254.e2. doi: 10.1016/j.jaci.2019.07.049. Epub 2019 Oct 21.
7
Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis.
Gastroenterology. 2020 Jan;158(1):111-122.e10. doi: 10.1053/j.gastro.2019.09.042. Epub 2019 Oct 5.
8
Single-cell RNA sequencing identifies inflammatory tissue T cells in eosinophilic esophagitis.
J Clin Invest. 2019 Apr 8;129(5):2014-2028. doi: 10.1172/JCI125917.
9
Molecular basis and cellular mechanisms of eosinophilic esophagitis for the clinical practice.
Expert Rev Gastroenterol Hepatol. 2019 Feb;13(2):99-117. doi: 10.1080/17474124.2019.1546120. Epub 2018 Nov 15.
10
Fibrostenotic eosinophilic esophagitis might reflect epithelial lysyl oxidase induction by fibroblast-derived TNF-α.
J Allergy Clin Immunol. 2019 Jul;144(1):171-182. doi: 10.1016/j.jaci.2018.10.067. Epub 2018 Dec 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验